NSC vs REPL · P/E 18, rev $12.12B vs $825.7M cap
Norfolk Southern Corporation (NSC) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported NSC revenue for 2024-12-31 was $12.12B. Net income was $2.62B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
REPL does not have a complete income-statement cache yet.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. REPL currently screens at market cap $825.7M.
Not investment advice. Open the NSC and REPL stock pages for the full models.
Not investment advice.